{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:38:44Z","timestamp":1782142724536,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ygyno.2011.06.015","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T04:14:09Z","timestamp":1309925649000},"page":"116-122","source":"Crossref","is-referenced-by-count":50,"title":["Promoter methylation analysis of WNT\/\u03b2-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix"],"prefix":"10.1016","volume":"123","clinical-trial-number":[{"clinical-trial-number":"isrctn20781131","registry":"10.18810\/isrctn"}],"author":[{"given":"W.F.","family":"van der Meide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Snellenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.L.M.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Baalbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.M.","family":"Helmerhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.B.","family":"van der Sluis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.F.","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.M.","family":"Steenbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.06.015_bb0005","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/ijc.20678","article-title":"Cervical cancer in the Netherlands 1989\u20131998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women","volume":"113","author":"Bulk","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/gyno.2000.5826","article-title":"The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States\u2014a 24-year population-based study","volume":"78","author":"Smith","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1097-0215(20000501)86:3<429::AID-IJC20>3.0.CO;2-D","article-title":"International trends in incidence of cervical cancer: II. Squamous-cell carcinoma","volume":"86","author":"Vizcaino","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0020","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U","article-title":"International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas","volume":"75","author":"Vizcaino","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.24410","article-title":"Screening and adenocarcinoma of the cervix","volume":"125","author":"Sasieni","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0030","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/sj.bjc.6601754","article-title":"Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence","volume":"90","author":"Zappa","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.bjc.6602915","article-title":"Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands","volume":"94","author":"Bulk","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention","volume":"98","author":"Castellsague","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0045","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1158\/1055-9965.EPI-05-0764","article-title":"Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline\/mildly dyskaryotic smear","volume":"15","author":"Berkhof","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0050","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ygyno.2010.12.361","article-title":"Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice","volume":"121","author":"Kinney","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijsu.2010.02.001","article-title":"Utility of DNA methylation markers for diagnosing cancer","volume":"8","author":"Qureshi","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.2598","article-title":"Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis","volume":"219","author":"Overmeer","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0065","article-title":"Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women","author":"Overmeer","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0070","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604055","article-title":"Sequential gene promoter methylation during HPV-induced cervical carcinogenesis","volume":"97","author":"Henken","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0075","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/ijc.21609","article-title":"Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma","volume":"118","author":"Kang","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0080","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/gcc.20590","article-title":"Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer","volume":"47","author":"Wilting","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0085","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.2741\/2368","article-title":"Wnt pathway and breast cancer","volume":"12","author":"Mohinta","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.surg.2008.05.007","article-title":"Regulation of metastasis in colorectal adenocarcinoma: a collision between development and tumor biology","volume":"144","author":"Smith","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1593\/neo.05607","article-title":"Aberrant Wnt\/beta-catenin signaling in pancreatic adenocarcinoma","volume":"8","author":"Zeng","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0100","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1158\/0008-5472.CAN-05-0455","article-title":"Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression","volume":"65","author":"Uren","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0105","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ygyno.2008.10.026","article-title":"SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway","volume":"112","author":"Chung","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000048688","article-title":"Frequent alterations of the beta-catenin protein in cancer of the uterine cervix","volume":"23","author":"Pereira-Suarez","year":"2002","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0115","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1006\/gyno.2001.6298","article-title":"Cytoplasmic\/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix","volume":"82","author":"Shinohara","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.virol.2009.10.011","article-title":"HPV16 E6 augments Wnt signaling in an E6AP-dependent manner","volume":"396","author":"Lichtig","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1158\/1541-7786.MCR-09-0345","article-title":"Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells","volume":"8","author":"Rampias","year":"2010","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijc.23913","article-title":"Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin","volume":"124","author":"Lee","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0135","first-page":"1982","article-title":"Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix","volume":"7","author":"Dong","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0140","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00432-009-0613-5","article-title":"Methylation analysis of SFRP genes family in cervical adenocarcinoma","volume":"135","author":"Lin","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2008.10.004","article-title":"Promoter methylation of SFRPs gene family in cervical cancer","volume":"112","author":"Chung","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/jnci\/djh031","article-title":"TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia","volume":"96","author":"Steenbergen","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0155","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0160","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JCM.35.3.791-795.1997","article-title":"A general primer GP5+\/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings","volume":"35","author":"Jacobs","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0165","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/JCM.40.3.779-787.2002","article-title":"GP5+\/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes","volume":"40","author":"van den Brule","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0170","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/01.ju.0000049627.90307.4d","article-title":"Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma","volume":"169","author":"Harden","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0175","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/path.2367","article-title":"Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC","volume":"215","author":"Overmeer","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0180","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4161\/epi.4.5.9371","article-title":"Epigenetic disruption of the WNT\/beta-catenin signaling pathway in human cancers","volume":"4","author":"Ying","year":"2009","journal-title":"Epigenetics"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0190","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1158\/0008-5472.CAN-05-0829","article-title":"Adenovirus-mediated overexpression of REIC\/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase","volume":"65","author":"Abarzua","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0195","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.1038\/sj.onc.1208138","article-title":"Dickkopf-3\/REIC functions as a suppressor gene of tumor growth","volume":"23","author":"Hsieh","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0200","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1038\/sj.onc.1209508","article-title":"Expression of Dickkopf genes is strongly reduced in malignant melanoma","volume":"25","author":"Kuphal","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0205","doi-asserted-by":"crossref","first-page":"531692","DOI":"10.1155\/2009\/531692","article-title":"High specificity of quantitative methylation-specific PCR analysis for MGMT promoter hypermethylation detection in gliomas","volume":"2009","author":"Parrella","year":"2009","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0210","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ijc.21017","article-title":"Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer","volume":"116","author":"Enokida","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0215","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1476-4598-5-28","article-title":"Methylation mediated silencing of TMS1\/ASC gene in prostate cancer","volume":"5","author":"Das","year":"2006","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0220","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1053\/j.gastro.2009.06.041","article-title":"Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis","volume":"137","author":"Du","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0225","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10549-009-0339-8","article-title":"Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer","volume":"119","author":"Fu","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0230","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1158\/0008-5472.CAN-07-6349","article-title":"Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0235","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/carcin\/bgi379","article-title":"Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer","volume":"27","author":"Ai","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0240","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00432-010-0763-5","article-title":"Epigenetic silencing of WIF-1 in hepatocellular carcinomas","volume":"136","author":"Deng","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0245","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20076","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women","volume":"110","author":"Bulkmans","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0250","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/ijc.24891","article-title":"Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study)","volume":"126","author":"Rijkaart","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0255","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ajog.2005.01.056","article-title":"Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence","volume":"193","author":"Elfgren","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0260","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","article-title":"HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial","volume":"95","author":"Kitchener","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2011.06.015_bb0265","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-10-2548","article-title":"Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women","volume":"17","author":"Hesselink","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811004823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811004823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T14:07:55Z","timestamp":1712585275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811004823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0090825811004823"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.06.015","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}